Phase 3 KEYNOTE-361 trial: Pembrolizumab (pembro) with or without chemotherapy versus chemotherapy alone in advanced urothelial cancer

Dokumenttyp:: Meeting Abstract
Autor(en):: Powles, T; Gschwend, JE; Loriot, Y; Bellmunt, J; Geczi, L; Vulsteke, C; Abdelsalam, M; Gafanov, R; Bae, WK; Revesz, J; Yamamoto, Y; Anido, U; Su, WP; Fleming, MT; Markus, M; Feng, D; Poehlein, CH; Alva, A
Titel:: Phase 3 KEYNOTE-361 trial: Pembrolizumab (pembro) with or without chemotherapy versus chemotherapy alone in advanced urothelial cancer
Zeitschriftentitel:: J Clin Oncol
Jahr:: 2017
Band / Volume:: 35 15
Seitenangaben Beitrag:: -
Sprache:: eng
Print-ISSN:: 0732-183X
TUM Einrichtung:: Urologische Klinik und Poliklinik
BibTeX

Vorkommen: